Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 14, 2012

View Archived Issues

New therapeutic target identified for schizophrenia

Nanoparticles targeting microRNA inhibit lymphoma

Novo Nordisk announces highlights of second quarter 2012

MultiCell Technologies updates on candidate dsRNA anticancer therapies

Protalix BioTherapeutics to begin clinical testing of candidate Fabry's disease drug

Bionor Pharma to conduct HIV vaccine combination study

AspenBio Pharma submits pre-IDE package for appendicitis test

Biofrontera and Pelpharma Handels sign distribution agreement

Scientists in China isolate new saponins from bunge fruit

Canadian university patents novel melanocortin MC4 receptor modulators

Compounds for ADHD treatment synthesized in France

New glutamate receptor antagonists presented by Taisho Pharmaceutical

Novel calcium channel antagonists developed at U.S. university

Nagasaki University reports new candidate anticancer products

Meritage Pharma launches trial in eosinophilic esophagitis

Recruitment complete in first stage of TACTT1 study

FDA extends PDUFA action date for Gattex NDA

Novel HCV entry inhibitor selected for further evaluation

New E.U. approval for Votrient

Second-generation Shigella vaccines designed in U.S.

PDUFA date for Santarus NDA extended

Tarceva approved in Canada for specific NSCLC subtype

FDA accepts for filing Teva's NDA for new oral contraceptive

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...